familial dysbetalipoproteinemia
MeSH: D006952ORPHA: 4121 Treatment Available
Overview
Human disease
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Lomitapide Orphan | Capsule | FDA Approved | 4 | — |
Clinical Presentation
Signs and symptoms associated with familial dysbetalipoproteinemia, sourced from HPO and Orphanet clinical annotations.
Abnormality of the skinHypertriglyceridemiaHypercholesterolemiaIncreased LDL cholesterol concentrationDecreased HDL cholesterol concentrationLipemia retinalisDiabetes mellitusEruptive xanthomasCorneal arcusXanthelasmaHepatic steatosisObesityHepatomegalyType IV atherosclerotic lesionTendon xanthomatosisXanthomas of the palmar creasesTuberous xanthomaRenal steatosisHypothyroidismAngina pectorisAcute pancreatitisGoutAccelerated atherosclerosisPeripheral arterial stenosisPremature coronary artery atherosclerosisAortic atherosclerotic lesion
Classification & Codes
MeSH Code
D006952Orphanet Code
ORPHA:412familial dysbetalipoproteinemia
| MeSH | D006952 |
| Orphanet | ORPHA:412 |
| Treatments | 1 drug(s) |
| Symptoms on record | 26 signs |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO